| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 标本采集类(元) | 128,733,793.59 | 259,021,108.41 | 115,625,621.59 | 488,243,748.66 | 189,522,031.62 |
| 穿刺护理类(元) | 792,534,968.23 | 1,786,300,253.80 | 944,352,701.02 | 1,943,103,195.09 | 941,978,759.32 |
| 穿刺介入类(元) | 32,308,007.42 | 24,113,509.41 | 13,205,036.55 | 159,260,650.31 | 154,314,257.86 |
| 医美类(元) | 39,999,729.56 | 70,987,803.56 | 21,420,568.86 | 63,700,346.20 | 22,860,933.05 |
| 其他产品(元) | 129,379,831.64 | 303,895,335.91 | 181,103,233.06 | 457,513,973.18 | 330,985,252.00 |
| 营业成本(元) | |||||
| 标本采集类(元) | 89,729,579.55 | 175,586,000.96 | - | 312,127,280.31 | - |
| 穿刺护理类(元) | 546,757,528.39 | 1,202,916,647.05 | - | 1,308,551,743.73 | - |
| 穿刺介入类(元) | 20,552,612.81 | 15,160,758.77 | - | 76,826,056.79 | - |
| 医美类(元) | 26,277,760.14 | 46,826,652.58 | - | 41,974,950.91 | - |
| 其他产品(元) | 100,598,790.55 | 214,045,058.74 | - | 326,058,376.50 | - |
| 毛利(元) | |||||
| 标本采集类(元) | 39,004,214.04 | 83,435,107.45 | - | 176,116,468.35 | - |
| 穿刺护理类(元) | 245,777,439.84 | 583,383,606.75 | - | 634,551,451.36 | - |
| 穿刺介入类(元) | 11,755,394.61 | 8,952,750.64 | - | 82,434,593.52 | - |
| 医美类(元) | 13,721,969.42 | 24,161,150.98 | - | 21,725,395.29 | - |
| 其他产品(元) | 28,781,041.09 | 89,850,277.17 | - | 131,455,596.68 | - |
| 毛利率(%) | |||||
| 标本采集类(%) | 30.30 | 32.21 | - | 36.07 | - |
| 穿刺护理类(%) | 31.01 | 32.66 | - | 32.66 | - |
| 穿刺介入类(%) | 36.39 | 37.13 | - | 51.76 | - |
| 医美类(%) | 34.31 | 34.04 | - | 34.11 | - |
| 其他产品(%) | 22.25 | 29.57 | - | 28.73 | - |
| 收入构成(%) | |||||
| 标本采集类(%) | 11.46 | 10.60 | 9.06 | 15.69 | 11.56 |
| 穿刺护理类(%) | 70.58 | 73.08 | 74.03 | 62.44 | 57.45 |
| 穿刺介入类(%) | 2.88 | 0.99 | 1.04 | 5.12 | 9.41 |
| 医美类(%) | 3.56 | 2.90 | 1.68 | 2.05 | 1.39 |
| 其他产品(%) | 11.52 | 12.43 | 14.20 | 14.70 | 20.19 |
| 毛利构成(%) | |||||
| 标本采集类(%) | 11.50 | 10.56 | - | 16.83 | - |
| 穿刺护理类(%) | 72.49 | 73.87 | - | 60.65 | - |
| 穿刺介入类(%) | 3.47 | 1.13 | - | 7.88 | - |
| 医美类(%) | 4.05 | 3.06 | - | 2.08 | - |
| 其他产品(%) | 8.49 | 11.38 | - | 12.56 | - |